Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Xavier, Maldonado"'
Autor:
Francesca Zacchi, Joan Carles, Macarena Gonzalez, Xavier Maldonado, Raquel Perez-Lopez, Maria Eugenia Semidey, Joaquin Mateo
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Despite the development of new therapies in the last few years, metastatic prostate cancer (PCa) is still a lethal disease. Radium-223 (Ra-223) is approved for patients with advanced castration-resistant prostate cancer (CRPC) with bone metastases an
Externí odkaz:
https://doaj.org/article/ecf8b1bc8e794feba090feadba35f493
Autor:
Almudena Zapatero, Xavier Maldonado Pijoan, Antonio Gómez-Caamaño, José Pardo Masferrer, Víctor Macías Hernández, Asunción Hervás Morón, Julia Luisa Muñoz García, Amalia Palacios Eito, Paloma Anguita-Alonso, Cristina González-Junco, José López Torrecilla
Publikováno v:
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-11 (2021)
Abstract Background Health-related quality of life (HRQoL) is greatly affected by prostate cancer (PCa) and associated treatments. This study aimed to measure the impact of radiotherapy on HRQoL and to further validate the Spanish version of the 16-i
Externí odkaz:
https://doaj.org/article/0f12d27526954c34b557d8ce235d1d99
Publikováno v:
Cancer Reports, Vol 5, Iss 9, Pp n/a-n/a (2022)
Abstract Background Intracranial germinomas (GN) are rare cancers that primarily affect children, making them rarer still in adults. Standard treatment for this neoplasm includes neoadjuvant chemotherapy (NC) followed by radiotherapy (RT) or RT at a
Externí odkaz:
https://doaj.org/article/2b725625a9854370abc20b757775062c
Autor:
Pedro C. Lara, Juan I. Rodríguez-Melcón, Amalia Palacios-Eito, Antonio Lozano, Asunción Hervás-Morón, Elena Villafranca, Alfonso Gómez-Iturriaga, Gemma Sancho, Xavier Maldonado
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundIntermediate-risk prostate cancer (PCa) is usually treated by a combination of external beam radiation therapy (EBRT) and a short course of androgen deprivation therapy (ADT). ADT is associated with multiple side effects, including weight g
Externí odkaz:
https://doaj.org/article/c70f8a99ebe74f68bb2aca7108584a78
Autor:
Giraldo, Alexandra, Cahuayme, Abraham André Arturo Geng, Peregrín, Blanca, Ramos, Mónica, d`Hebron, Xavier Maldonado Vall
Publikováno v:
In Radiotherapy and Oncology May 2024 194 Supplement 1:S1757-S1761
Autor:
Maria Antonia Gómez-Aparicio, Fernando López-Campos, Lira Pelari-Mici, David Buchser, Jorge Pastor, Xavier Maldonado, Juan Zafra, Alison C. Tree, Renée Bultijnck, Paul Sargos, Piet Ost, Felipe Couñago
Publikováno v:
Frontiers in Bioscience-Landmark, Vol 27, Iss 1, p 034 (2022)
Prostate cancer is the most frequent genitourinary tumor worldwide. Maintaining an optimum bone health throughout the natural course of prostate cancer is an important aspect in the management of this disease, particularly in this at risk population
Externí odkaz:
https://doaj.org/article/814f73e8132b4fdc96673cbfbb7c2734
Autor:
Marta Bonet, David González, José-Enrique Baquedano, Elena García, Manuel Altabas, Francesc Casas, Nicolás Feltes, Ferran Ferrer, Palmira Foro, Rafael Fuentes, Manuel Galdeano, David Gomez, Ivan Henriquez, Josep Jové, Joan Lozano, Xavier Maldonado, Joel Mases, Ismael Membrive, Saturio Paredes, Àlvar Roselló, Gemma Sancho, Moisés Mira
Publikováno v:
Clinical and Translational Oncology. 25:1017-1023
To reach a consensus on recommendations for the management of high-risk and post-operative non-metastatic prostate cancer by a group of Radiation Oncologists in Catalonia dedicated to prostate cancer.A modified Delphi approach was employed to reach c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c41dc171d710ad23e58b46bec99af64
https://doi.org/10.1007/s12094-022-03005-4
https://doi.org/10.1007/s12094-022-03005-4
Autor:
Amar U. Kishan, Xiaoyan Wang, Yilun Sun, Tahmineh Romero, Jeff M. Michalski, Ting Martin Ma, Felix Y. Feng, Howard M. Sandler, Michel Bolla, Philippe Maingon, Theo De Reijke, Anouk Neven, Allison Steigler, James W. Denham, David Joseph, Abdenour Nabid, Nathalie Carrier, Luis Souhami, Matt R. Sydes, David P. Dearnaley, Isabel Syndikus, Alison C. Tree, Luca Incrocci, Wilma D. Heemsbergen, Floris J. Pos, Almudena Zapatero, Jason A. Efstathiou, Araceli Guerrero, Ana Alvarez, Carmen Gonzalez San-Segundo, Xavier Maldonado, Michael Xiang, Matthew B. Rettig, Robert E. Reiter, Nicholas G. Zaorsky, Wee Loon Ong, Robert T. Dess, Michael L. Steinberg, Nicholas G. Nickols, Soumyajit Roy, Jorge A. Garcia, Daniel E. Spratt
Publikováno v:
European Urology, 82(1), 106-114. Elsevier
European urology, 82(1), 106-114. Elsevier
European urology, 82(1), 106-114. Elsevier
Background: The relative benefits of radiotherapy (RT) dose escalation and the addition of short-term or long-term androgen deprivation therapy (STADT or LTADT) in the treatment of prostate cancer are unknown. Objective: To perform a network meta-ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33f45f1d93c0238bd6e091ba39814978
http://www.scopus.com/inward/record.url?scp=85131903134&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85131903134&partnerID=8YFLogxK
Autor:
Almudena Zapatero, Araceli Guerrero, Xavier Maldonado, Ana Álvarez, Carmen González San-Segundo, María Ángeles Cabeza Rodríguez, Josep María Solé, Agustí Pedro Olivé, Francesc Casas, Ana Boladeras, Carmen Martín de Vidales, María Luisa Vázquez de la Torre, Susana Vara, Juan Luis Sanz, Felipe A Calvo
Publikováno v:
The Lancet Oncology. 23:671-681
The optimal duration of androgen deprivation combined with high-dose radiotherapy in prostate cancer remains controversial. The DART 01/05 trial was designed to determine whether long-term androgen deprivation is superior to short-term androgen depri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53055bf1e2151c6b7c1d053bdd7c7ab3
https://doi.org/10.1016/s1470-2045(22)00190-5
https://doi.org/10.1016/s1470-2045(22)00190-5
Autor:
Amar U Kishan, Yilun Sun, Holly Hartman, Thomas M Pisansky, Michel Bolla, Anouk Neven, Allison Steigler, James W Denham, Felix Y Feng, Almudena Zapatero, John G Armstrong, Abdenour Nabid, Nathalie Carrier, Luis Souhami, Mary T Dunne, Jason A Efstathiou, Howard M Sandler, Araceli Guerrero, David Joseph, Philippe Maingon, Theo M de Reijke, Xavier Maldonado, Ting Martin Ma, Tahmineh Romero, Xiaoyan Wang, Matthew B Rettig, Robert E Reiter, Nicholas G Zaorsky, Michael L Steinberg, Nicholas G Nickols, Angela Y Jia, Jorge A Garcia, Daniel E Spratt
Publikováno v:
The Lancet Oncology, 23(2), 304-316. Lancet Publishing Group
Background: Randomised trials have investigated various androgen deprivation therapy (ADT) intensification strategies in men receiving radiotherapy for the treatment of prostate cancer. This individual patient data meta-analysis of relevant randomise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceff0c87a7bfb4907535e1b24de5460b
https://doi.org/10.1016/s1470-2045(21)00705-1
https://doi.org/10.1016/s1470-2045(21)00705-1